Jason Zemansky
Stock Analyst at Bank of America Securities
(4.79)
# 516
Out of 4,455 analysts
446
Total ratings
58.8%
Success rate
19.7%
Average return
Main Sectors:
Stocks Rated by Jason Zemansky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CYTK Cytokinetics | Maintained: Hold | $67 → $83 | $82.19 | +0.99% | 46 | Jun 16, 2026 | |
| INSM Insmed | Maintained: Buy | $214 | $103.38 | +107.00% | 48 | Jun 11, 2026 | |
| MDGL Madrigal Pharmaceuticals | Reiterated: Hold | $550 → $542 | $512.65 | +5.73% | 24 | Jun 11, 2026 | |
| RCKT Rocket Pharmaceuticals | Maintained: Buy | $10 | $3.25 | +207.69% | 18 | Jun 11, 2026 | |
| BBIO BridgeBio Pharma | Maintained: Buy | $101 | $70.24 | +43.79% | 33 | Jun 11, 2026 | |
| ABOS Acumen Pharmaceuticals | Maintained: Buy | $8 | $2.36 | +238.98% | 13 | Jun 11, 2026 | |
| TYRA Tyra Biosciences | Reiterated: Buy | $37 → $42 | $31.88 | +31.74% | 15 | Jun 10, 2026 | |
| TVTX Travere Therapeutics | Maintained: Buy | $59 | $58.85 | +0.25% | 28 | Jun 3, 2026 | |
| KURA Kura Oncology | Reiterated: Buy | $30 | $10.90 | +175.23% | 38 | Jun 3, 2026 | |
| KROS Keros Therapeutics | Reiterated: Hold | $20 | $10.99 | +81.98% | 16 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.91 | +214.14% | 4 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $12 | $11.61 | +3.36% | 11 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $32 | $11.45 | +179.48% | 3 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $266 | $303.59 | -12.38% | 7 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 | $21.31 | +36.09% | 32 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $203 | $216.03 | -6.03% | 11 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 | $31.00 | -19.35% | 36 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $1.78 | $3.17 | -43.85% | 33 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.323 | +2,067.18% | 19 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $59.00 | n/a | 2 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $15 → $12 | $4.50 | n/a | 4 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $1 | $4.32 | n/a | 3 | Dec 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $13.17 | n/a | 2 | Nov 17, 2023 |
Cytokinetics
Jun 16, 2026
Maintained: Hold
Price Target: $67 → $83
Current: $82.19
Upside: +0.99%
Insmed
Jun 11, 2026
Maintained: Buy
Price Target: $214
Current: $103.38
Upside: +107.00%
Madrigal Pharmaceuticals
Jun 11, 2026
Reiterated: Hold
Price Target: $550 → $542
Current: $512.65
Upside: +5.73%
Rocket Pharmaceuticals
Jun 11, 2026
Maintained: Buy
Price Target: $10
Current: $3.25
Upside: +207.69%
BridgeBio Pharma
Jun 11, 2026
Maintained: Buy
Price Target: $101
Current: $70.24
Upside: +43.79%
Acumen Pharmaceuticals
Jun 11, 2026
Maintained: Buy
Price Target: $8
Current: $2.36
Upside: +238.98%
Tyra Biosciences
Jun 10, 2026
Reiterated: Buy
Price Target: $37 → $42
Current: $31.88
Upside: +31.74%
Travere Therapeutics
Jun 3, 2026
Maintained: Buy
Price Target: $59
Current: $58.85
Upside: +0.25%
Kura Oncology
Jun 3, 2026
Reiterated: Buy
Price Target: $30
Current: $10.90
Upside: +175.23%
Keros Therapeutics
Jun 3, 2026
Reiterated: Hold
Price Target: $20
Current: $10.99
Upside: +81.98%
Jun 3, 2026
Reiterated: Buy
Price Target: $6
Current: $1.91
Upside: +214.14%
Jun 3, 2026
Reiterated: Sell
Price Target: $12
Current: $11.61
Upside: +3.36%
Jun 3, 2026
Reiterated: Buy
Price Target: $34 → $32
Current: $11.45
Upside: +179.48%
Jun 2, 2026
Maintained: Buy
Price Target: $266
Current: $303.59
Upside: -12.38%
May 21, 2026
Maintained: Buy
Price Target: $29
Current: $21.31
Upside: +36.09%
May 14, 2026
Maintained: Hold
Price Target: $203
Current: $216.03
Upside: -6.03%
Apr 21, 2026
Maintained: Hold
Price Target: $25
Current: $31.00
Upside: -19.35%
Mar 30, 2026
Maintained: Sell
Price Target: $1.78
Current: $3.17
Upside: -43.85%
Feb 17, 2026
Reiterated: Buy
Price Target: $7
Current: $0.323
Upside: +2,067.18%
Oct 30, 2024
Maintained: Buy
Price Target: n/a
Current: $59.00
Upside: n/a
Mar 28, 2024
Reiterated: Sell
Price Target: $15 → $12
Current: $4.50
Upside: n/a
Dec 26, 2023
Maintained: Sell
Price Target: $1
Current: $4.32
Upside: n/a
Nov 17, 2023
Rated: Hold
Price Target: n/a
Current: $13.17
Upside: n/a